Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NuGen Medical DevicesNGMDF 3-Year EBITDA Growth Rate is 25.20% as of Mar. 2026, which is at its 10-year median of 25.20. The stock has 7 warning signs investors should review. Among 692 Medical Devices & Instruments companies, NuGen Medical Devices ranks better than 72.25% on this metric.
During the past 12 months, NuGen Medical Devices's average EBITDA Per Share Growth Rate was -600.00% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 25.20% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 19.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of NuGen Medical Devices was 42.60% per year. The lowest was -13.60% per year. And the median was 25.20% per year.
NuGen Medical Devices (OTCPK:NGMDF) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
NuGen Medical Devices 3-Year EBITDA Growth Rate Related Terms
NGMDF vs ABT, SYK, MDT: 3-Year EBITDA Growth Rate Comparison
For the Medical Devices subindustry, NuGen Medical Devices's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NuGen Medical Devices 3-Year EBITDA Growth Rate vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, NuGen Medical Devices's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where NuGen Medical Devices's 3-Year EBITDA Growth Rate falls into.
NuGen Medical Devices 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 25.20% mean?
NuGen Medical Devices (NGMDF) has a 3-Year EBITDA Growth Rate of 25.20% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for NuGen Medical Devices and its competitors. This is near median its historical median of 25.20. According to the industry distribution chart, NuGen Medical Devices ranks #192 out of 692 companies in the Medical Devices & Instruments industry, placing it in the top 27.7%.
Is NuGen Medical Devices' 3-Year EBITDA Growth Rate too high?
NuGen Medical Devices' current 3-Year EBITDA Growth Rate of 25.20% is near median its 10-year median of 25.20. The Medical Devices & Instruments industry median 3-Year EBITDA Growth Rate is 7.65. NuGen Medical Devices' value of 25.20% is 229.4% above this industry median. Based on the distribution chart, NuGen Medical Devices ranks #192 out of 692 companies in the Medical Devices & Instruments industry, which is above the industry midpoint.
How does NuGen Medical Devices' 3-Year EBITDA Growth Rate compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, NuGen Medical Devices ranks #192 out of 692 companies for 3-Year EBITDA Growth Rate. This puts NuGen Medical Devices in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 7.65. NuGen Medical Devices' value of 25.20% is 229.4% above this benchmark. While the company's 10-year median is 25.20 vs. the industry median of 7.65, NuGen Medical Devices has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Medical Devices & Instruments company?
The median 3-Year EBITDA Growth Rate among Medical Devices & Instruments companies is 7.65, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NuGen Medical Devices's current 3-Year EBITDA Growth Rate of 25.20% is 229.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for NuGen Medical Devices and its competitors. For the Medical Devices & Instruments industry, the median 3-Year EBITDA Growth Rate is 7.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NuGen Medical Devices's current 3-Year EBITDA Growth Rate is 25.20%, which is near median its own 10-year median of 25.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NuGen Medical Devices stock overvalued right now?
Based on GuruFocus' analysis, NuGen Medical Devices (NGMDF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.02, compared to a current price of $0.02 — trading 21.8% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 25.20%, which is near median its 10-year median of 25.20 and 229.4% above the Medical Devices & Instruments industry median of 7.65. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For NuGen Medical Devices (NGMDF), the current 3-Year EBITDA Growth Rate is 25.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NuGen Medical Devices Inc is a medical device manufacturing company specializing in the field of needleless injections and related technologies. The reportable segment of the company is the manufacturing of needle injector devices. Geographically, the company generates revenue from Europe, followed by Asia, and other.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NGMDF has been successfully added to your 
